Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.48M
3.25K shares
What this filing means
WAGNER CHARLES F JR plans to sell 3.25K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/28/2024ACC: 0001959173-24-003906
Officer· EVP and CFO
Since Apr 2019
3.25K
Shares to sell
$1.48M
Approx. market value
3.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/13/2023
2.05KRestricted Stock Vesting
Compensation
2/10/2023
1.20KTotal acquired3.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2023 | Restricted Stock Vesting Compensation | 2.05K | — |
2/10/2023 | Restricted Stock Vesting Compensation | 1.20K | — |
| Total | 3.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.25K
Market value
$1.48M
5/28/2024
Total
Units
3.25K
Value
$1.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/28/2024 | 3.25K | $1.48M | NASDAQ | Planned |
| Total | 3.25K | $1.48M | ||